Revisiting Interleukin-12 as a Cancer Immunotherapy Agent

被引：69

作者：

Berraondo, Pedro ^{[1
,2
,3
]}

Etxeberria, Inaki ^{[1
,2
]}

Ponz-Sarvise, Mariano ^{[2
,4
,5
]}

Melero, Ignacio ^{[1
,2
,3
,4
,5
]}

机构：

[1] Univ Navarra, Ctr Appl Med Res CIMA, Immunol & Immunotherapy Program, Pamplona, Spain

[2] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain

[3] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

[4] CUN, Dept Oncol, Pamplona, Spain

[5] CUN, Dept Immunol, Pamplona, Spain

来源：

CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 12期

关键词：

T-CELL TRANSFER; DOXORUBICIN; THERAPY;

D O I：

10.1158/1078-0432.CCR-18-0381

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

IL12 antitumor activities are mediated by the activation of T and natural killer (NK) lymphocytes to produce IFNg. Systemically, recombinant IL12 has a narrow therapeutic window that favors local delivery, for instance, by gene therapy approaches. IL12 is a powerful partner in immunotherapy combinations with checkpoint inhibitors and adoptive T-cell transfer. (C) 2018 AACR.

引用

收藏

页码：2716 / 2718

页数：3

相关论文

共 11 条

[1] Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer [J].

Alizadeh, Darya ;

Trad, Malika ;

Hanke, Neale T. ;

Larmonier, Claire B. ;

Janikashvili, Nona ;

Bonnotte, Bernard ;

Katsanis, Emmanuel ;

Larmonier, Nicolas .

CANCER RESEARCH, 2014, 74 (01) :104-118

[2] Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon γ production from CD4+ versus CD8+ T cells [J].

Carter, LL ;

Murphy, KM .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (08) :1355-1360

[3] Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death [J].

Casares, N ;

Pequignot, MO ;

Tesniere, A ;

Ghiringhelli, F ;

Roux, S ;

Chaput, N ;

Schmitt, E ;

Hamai, A ;

Hervas-Stubbs, S ;

Obeid, M ;

Coutant, F ;

Métivier, D ;

Pichard, E ;

Aucouturier, P ;

Pierron, G ;

Garrido, C ;

Zitvogel, L ;

Kroemer, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) :1691-1701

[4] Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody [J].

Fallon, Jonathan K. ;

Vandeveer, Amanda J. ;

Schlom, Jeffrey ;

Greiner, John W. .

ONCOTARGET, 2017, 8 (13) :20558-20571

[5] Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice [J].

Hsu, Fei-Ting ;

Chen, Tzu-Chun ;

Chuang, Hui-Yen ;

Chang, Ya-Fang ;

Hwang, Jeng-Jong .

ONCOTARGET, 2015, 6 (42) :44134-44150

[6] T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors [J].

Hu, Jiemiao ;

Sun, Chuang ;

Bernatchez, Chantale ;

Xia, Xueqing ;

Hwu, Patrick ;

Dotti, Gianpietro ;

Li, Shulin .

CLINICAL CANCER RESEARCH, 2018, 24 (12) :2920-2934

[7] Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts [J].

Kerkar, Sid P. ;

Muranski, Pawel ;

Kaiser, Andrew ;

Boni, Andrea ;

Sanchez-Perez, Luis ;

Yu, Zhiya ;

Palmer, Douglas C. ;

Reger, Robert N. ;

Borman, Zachary A. ;

Zhang, Ling ;

Morgan, Richard A. ;

Gattinoni, Luca ;

Rosenberg, Steven A. ;

Trinchieri, Giorgio ;

Restifo, Nicholas P. .

CANCER RESEARCH, 2010, 70 (17) :6725-6734

[8] Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level [J].

Mazzolini, G ;

Qian, C ;

Narvaiza, I ;

Barajas, M ;

Borrás-Cuesta, F ;

Xie, XM ;

Duarte, M ;

Melero, I ;

Prieto, J .

HUMAN GENE THERAPY, 2000, 11 (01) :113-125

[9] Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade [J].

Quetglas, Jose I. ;

Labiano, Sara ;

Aznar, M. Angela ;

Bolanos, Elixabet ;

Azpilikueta, Arantza ;

Rodriguez, Inmaculada ;

Casales, Erkuden ;

Sanchez-Paulete, Alfonso R. ;

Segura, Victor ;

Smerdou, Cristian ;

Melero, Ignacio .

CANCER IMMUNOLOGY RESEARCH, 2015, 3 (05) :449-454

[10] Gene therapy of cancer based on interleukin 12 [J].

Sangro, B ;

Melero, I ;

Qian, C ;

Prieto, J .

CURRENT GENE THERAPY, 2005, 5 (06) :573-581